Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Capsule Sponge Study in Eosinophilic Oesophagitis

NCT: NCT06501274 · COMPLETED

NCT IDNCT06501274
StatusCOMPLETED
Start Date2023-07-31
Completion2025-12-31
SponsorEast and North Hertfordshire NHS Trust (OTHER_GOV)
First posted
Last updated

Brief Summary

Open pragmatic, descriptive single site study in adult patients with non-stenotic eosinophilic oesophagitis. To assess the clinical value of Capsule sponge in the assessment of treatment response in patients with known non-stenosing eosinophilic oesophagitis, as an alternative to gastroscopy in a real world setting. To assess patient preference for Capsule sponge or gastroscopy. All patients with non-stenosing eosinophilic oesophagitis who are reviewed in clinic that have not had reassessment of their oesophagus post treatment initiation or change in treatment will be offered Capsule sponge as an alternative to gastroscopy. A standardised clinical symptom questionnaire will be self-administered for 2w prior to clinic visits and Capsule sponge. Telephone triage for safety check and exclusion criteria by Capsule sponge nurse. A patient symptom questionnaire at the time of procedure by research nurse. A patient satisfaction survey will be delivered after the Capsule sponge procedure by Capsule sponge nurse. Cytological assessment of the Capsule sponge and eosinophil count and other markers of inflammation will be reported by Cyted. Clinic follow up will occur at approximately 6-8 weeks post Capsule sponge. Descriptive Changes in management as a result of the Capsule sponge findings and /or symptoms will be recorded by clinician.

Frequently Asked Questions

What is Capsule Sponge Study in Eosinophilic Oesophagitis?

Capsule Sponge Study in Eosinophilic Oesophagitis is a clinical trial registered under NCT06501274. Current status: COMPLETED.

What is the status of NCT06501274?

The current status of NCT06501274 (Capsule Sponge Study in Eosinophilic Oesophagitis) is: COMPLETED.

When did Capsule Sponge Study in Eosinophilic Oesophagitis start?

Capsule Sponge Study in Eosinophilic Oesophagitis started on 2023-07-31.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.